Single-Cell Regulatory Network Analysis Identifies Adjunctive Drug Candidates in Early Risankizumab-Treated Psoriasis
Year: 2026
Type: article
Source: Current Pharmaceutical Design
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7125515762
FWCI:
Cites:
Cited by:
Related to:
